Author

Tanvir Kabir

Observed names: Kabir, Tanvir, Tanvir F Kabir, Tanvir F. Kabir

Institutions: Mayo Clinic, University of Louisville, University of Kentucky, University of Washington

Observed institutions: Mayo Clinic, University of Louisville, University of Kentucky, University of Washington

ORCID: 0000-0001-9028-4446

Observed ORCID: 0000-0001-9028-4446

OpenAlex ID: A5069724922

Fat Graft Enrichment Strategies: A Systematic Review

2020 · Krishna S. Vyas, Henry C. Vasconez, et al. · Plastic & Reconstructive Surgery · 86

Immunotherapy for Medulloblastoma: Current Perspectives

2020 · Tanvir F Kabir, Charles A Kunos, et al. · ImmunoTargets and Therapy · 49

Immune Checkpoint Inhibitors in Pediatric Solid Tumors: Status in 2018

2018 · Tanvir F. Kabir, Aman Chauhan, et al. · Ochsner Journal · 42

The Clinical Characteristics of Multiple Myeloma in the Acute Care Setting: Case Presentation and Clinical Recommendations

2020 · Daniel R Zetter, Tanvir Kabir, et al. · Cureus

Prognostic and predictive factors associated with ipilimumab-related adverse events: a retrospective analysis of 11 NCI-sponsored phase I clinical trials

2020 · Aman Chauhan, Tanvir Kabir, et al. · Oncotarget

Prognostic and predictive factors associated with ipilimumab related adverse events: A retrospective analysis of 11 NCI sponsored ipilimumab phase I clinical trials.

2019 · Aman Chauhan, Tanvir Kabir, et al. · Journal of Clinical Oncology

Works count: 7

Citation count: 177

H-index: 3

I10-index: 3